Evidence map›Paper›PMID 23792768›Full record

ArticleDifferentiation; research in biological diversity

Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Tristan M Nicholson, Priyanka D Sehgal, Sally A Drew, Wei Huang, William A Ricke

Abstract read
In one paragraph

Article in Differentiation; research in biological diversity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Enhanced prostatic Esr1The Journal of pathology · 2024
    Article
  5. Article
  6. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  7. Article
  8. Nutrients · 2023
    Article
  9. Article
  10. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS.American journal of physiology. Renal physiology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tristan M NicholsonDepartment of Urology, University of Wisconsin, Madison, WI, USA.
Priyanka D Sehgal
Sally A Drew
Wei Huang
William A Ricke
University of Wisconsin–Madison · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
Estrogen Regulation in BPH and the Lower Urinary TractR01DK093690 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RICKE, WILLIAM A · 2011 to 2014
$1.3M
Bisphenol A: Urine flow disorder and prostate pathologyRC2ES018764 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI RICKE, WILLIAM A, VOM SAAL, FREDERICK S · 2009 to 2010
$1.1M
Estrogen receptors in benign prostatic hyperplasiaF30DK093173 · NIDDK · UNIVERSITY OF ROCHESTER · PI NICHOLSON, TRISTAN MARRINER · 2012 to 2014
$138k
NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1TR000427NIDDK NIH HHS DK093690NIDDK NIH HHS F30 DK093173NIDDK NIH HHS F30DK093173NIDDK NIH HHS R01 DK093690NIEHS NIH HHS ES018764NIEHS NIH HHS RC2 ES018764NIGMS NIH HHS T32 GM007356NIGMS NIH HHS T32GM07356
6 · The paper itself

Abstract

Androgens and estrogens, acting via their respective receptors, are important in benign prostatic hyperplasia (BPH). The goals of this study were to quantitatively characterize the tissue distribution and staining intensity of androgen receptor (AR) and estrogen receptor-alpha (ERα), and assess cells expressing both AR and ERα, in human BPH compared to normal prostate. A tissue microarray composed of normal prostate and BPH tissue was used and multiplexed immunohistochemistry was performed to detect AR and ERα. We used a multispectral imaging platform for automated scanning, tissue and cell segmentation and marker quantification. BPH specimens had an increased number of epithelial and stromal cells and increased percentage of epithelium. In both stroma and epithelium, the mean nuclear area was decreased in BPH relative to normal prostate. AR expression and staining intensity in epithelial and stromal cells was significantly increased in BPH compared to normal prostate. ERα expression was increased in BPH epithelium. However, stromal ERα expression and staining intensity was decreased in BPH compared to normal prostate. Double positive (AR and ERα) epithelial cells were more prevalent in BPH, and fewer double negative (AR and ERα) stromal and epithelial negative cells were observed in BPH. These data underscore the importance of tissue layer localization and expression of steroid hormone receptors in the prostate. Understanding the tissue-specific hormone action of androgens and estrogens will lead to a better understanding of mechanisms of pathogenesis in the prostate and may lead to better treatment for BPH.

Indexed as

AdultAgedEpitheliumEstrogen Receptor alphaGene ExpressionHumansImmunohistochemistryMaleMiddle AgedProstateProstatic HyperplasiaReceptors, AndrogenStromal CellsAR protein, humanESR1 protein, humanEstrogen Receptor alphaReceptors, Androgen5-alpha reductase inhibitors5ARIACTA2androgen receptorAndrogen receptorARbenign prostatic hyperplasiaBenign prostatic hyperplasiaBPHDABd-amino benzeneERαestrogen receptor-alphaEstrogen receptor-alphahematoxylinHTIHCimmunohistochemistrylower urinary tract symptomsLUTSprostate specific antigenPSAselective estrogen receptor modulatorsSERMssmooth muscle alpha-actintissue microarrayTMAtransurethral resection of the prostateTURP

Identifiers

PMID23792768
PMCPMC3729928
OpenAlexW1988091239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.